Philip is a Pharmaceutical Project Lead at Roche, where he supports clinical-stage gene therapy and biologics programs. He earned a PhD in Pharmaceutical Sciences from the University of Basel and has extensive experience in both academic and industrial research. His expertise spans drug delivery systems, including lipid- and polymer-based nanoparticles, extracellular vesicles, drug conjugates, and cell and gene therapy technical development.